CLDI

CALIDI BIOTHERAPEUTICS, INC.

CLDI · CIK 1855485 · Annual (10-K) · Last 4 years

Financial Trends

Revenue
20212024
Net Income−$22M
20212024
Operating CF−$20M
20212024
Free Cash Flow
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue—$0.0B——
Cost of Revenue————
Gross Profit————
R&D Expense$0.0B$0.0B——
SG&A Expense$0.0B$0.0B——
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$0.0B$0.0B
EPS (Basic)$-2.97$1.73——
EPS (Diluted)$-2.97$1.73——

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.0B$0.0B$0.0B$0.2B
Current Assets$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$-0.0B$-0.0B$-0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.0B$-0.0B$0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B$0.2B$-0.2B
Capital Expenditures————
Financing Cash Flow$0.0B$0.0B$-0.2B$0.2B
← Companies